A Systematic Review of Network Meta-Analyses and Real-World Evidence Comparing Apixaban and Rivaroxaban in Nonvalvular Atrial Fibrillation

by Nathan R. Hill D.Phil, Belinda Sandler MBBS, BSc, MRCP, Evelien Bergrath MSc, Dušan Milenković MSc, Ajibade O. Ashaye MD, MBA, MPH, MSc, Usman Farooqui MFPM, MSc, Alexander T. Cohen MD
Published 2020-01-01